Mylan Earnings Preview: Can This Streak Continue?

Mylan (NASDAQ:MYL) will report earnings after markets close on Thursday, May 2nd. Mylan Inc. is a global generic and specialty pharmaceuticals company. The Company operates an active pharmaceutical ingredient manufacturer and runs a specialty business focused on respiratory, allergy, and psychiatric therapies.

Here is your Cheat Sheet to Mylan Earnings:

Earnings Expectations: Analysts expect earnings of $0.62 per share on revenues of $1.69 billion. Currently, the company’s P/E ratio stands at 19.26.

Analyst Trends:

Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a profit of $0.66 to a profit $0.69. For the current year, the average estimate is a profit of $2.87, which is better than the estimate ninety days ago.

Earnings Trends:

Here’s how Mylan has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 5,138 5,093 5,451 6,130 6,796
Diluted EPS ($) -1.05 0.30 0.68 1.22 1.52

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Dec. 31, 2011 Mar. 31, 2012 Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012
Revenue ($) in millions 1,531 1,592 1,692 1,810 1,702
Diluted EPS ($) 0.3014 0.30 0.33 0.51 0.3925

Past Performance:
Mylan has beat analyst estimates 4 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at]